MCM
AGN

Moore Capital Management’s Allergan plc AGN Stock Holding History

Moore Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-210,000
Closed -$37.2M – 325
2020
Q1 		$37.2M Buy
210,000
+10,000
+5% +$1.88M 1.54% 15
2019
Q4 		$38.2M Buy
+200,000
New +$36.1M 1.25% 17
2016
Q1 		– Sell
-6,816
Closed -$2.13M – 366
2015
Q4 		$2.13M Buy
+6,816
New +$2.03M 0.07% 206
2015
Q3 		– Sell
-19,346
Closed -$5.87M – 447
2015
Q2 		$5.87M Sell
19,346
-11,870
-38% -$3.54M 0.13% 164
2015
Q1 		$9.29M Buy
31,216
+23,550
+307% +$6.71M 0.2% 102
2014
Q4 		$1.97M Sell
7,666
-20,970
-73% -$5.24M 0.06% 229
2014
Q3 		$6.91M Sell
28,636
-18,712
-40% -$4.19M 0.16% 170
2014
Q2 		$10.6M Buy
47,348
+42,345
+846% +$8.77M 0.25% 98
2014
Q1 		$1.03M Buy
+5,003
New +$991K 0.02% 310
2013
Q3 		– Sell
-20,000
Closed -$2.52M – 455
2013
Q2 		$2.52M Buy
+20,000
New +$2.26M 0.06% 196

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Moore Capital Management's AGN Position: Q2 2020 in Review

Moore Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 210,000 shares — an estimated $37.2M sold.

Moore Capital Management first reported a position in AGN in Q2 2013 and held it in 10 quarters. The position peaked at $38.2M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Moore Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Moore Capital Management sold 210,000 Allergan plc shares in Q2 2020, an estimated $37.2M.
  • Moore Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 10 quarters.
  • Moore Capital Management's Allergan plc position peaked at $38.2M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Moore Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.